Orthomimetics acquired by TiGenix NV
Oxford Capital portfolio company Orthomimetics has been acquired by Belgian listed biotech company TiGenix. Orthomimetics' flagship product has received CE Mark approval and is close to entering the European market.
Click here to read the full Press Release.
